Sherona Sirkisoon
-
- Cancer, Hypoxia, and Metabolism 2
-
- Cancer-related Molecular Pathways 4
-
- Glioma Diagnosis and Treatment 2
-
- Hedgehog Signaling Pathway Studies 7
- Ubiquitin and proteasome pathways 4
- FOXO transcription factor regulation 3
- Histone Deacetylase Inhibitors Research 2
-
- Cancer Mechanisms and Therapy 3
- Co-authors
- Hui‐Wen LoRichard L. CarpenterKounosuke WatabeTadas RimkusWaldemar DebinskiFei XingMichael D. ChanDongqin Zhu
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- United StatesChina
In The Last Decade
Sherona Sirkisoon
16 papers receiving 438 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 109
- Oncology 193
- Genetics 54
- Molecular Biology 286
- Pathology and Forensic Medicine 48
Countries citing papers authored by Sherona Sirkisoon
This map shows the geographic impact of Sherona Sirkisoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherona Sirkisoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherona Sirkisoon more than expected).
Fields of papers citing papers by Sherona Sirkisoon
This network shows the impact of papers produced by Sherona Sirkisoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherona Sirkisoon. The network helps show where Sherona Sirkisoon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sherona Sirkisoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 38 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 12 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 9 | |
| 8 | 2020 | 63 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 72 | |
| 11 | 2018 | 32 | |
| 12 | 2018 | 79 | |
| 13 | 2017 | 11 | |
| 14 | Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers. | 2017 | 24 |
| 15 | 2017 | 35 | |
| 16 | 2015 | 44 |
About Sherona Sirkisoon
Sherona Sirkisoon is a scholar working on Oncology, Molecular Biology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 16 papers that have together received 439 indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (7 papers), Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers), Cancer Mechanisms and Therapy (3 papers), FOXO transcription factor regulation (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Glioma Diagnosis and Treatment (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Cancer Research (109 citations), Oncology (193 citations), Genetics (54 citations), Molecular Biology (286 citations) and Pathology and Forensic Medicine (48 citations). Sherona Sirkisoon has collaborated with scholars based in United States and China. Frequent co-authors include Hui‐Wen Lo, Richard L. Carpenter, Kounosuke Watabe, Tadas Rimkus, Waldemar Debinski, Fei Xing, Michael D. Chan, Dongqin Zhu, Guangxu Jin and Daniel Doheny. Their work appears in journals such as Oncogene, Cancer Research, Cancer Letters, Oncotarget and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.